Adcock Ingram Holdings Ltd (AIHLF)
2.45
0.00 (0.00%)
USD |
OTCM |
Dec 13, 16:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 359.57M |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 3.48% |
Valuation | |
PE Ratio | 8.694 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 0.7336 |
Price to Book Value | 1.251 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.0852 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.00 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | -- |
Profile
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India. |
URL | https://www.adcock.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Sep. 18, 2024 |
Ratings
Profile
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company's reportable segment include Consumer, OTC, Prescription, Hospital and Other-shared services, out of which it generates maximum revenue from Prescription segment. Geographically it operates in Southern Africa and India. |
URL | https://www.adcock.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Pharmaceuticals |
Equity Style | Small Cap/Blend |
Next Earnings Release | N/A |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Sep. 18, 2024 |